|Russell Microcap® Growth Index||16.00||-1.43||10.81||3.50||14.77||-|
|Russell 2000® Growth Index||17.14||3.85||14.87||8.41||16.52||7.96|
Seeks long-term capital appreciation by investing in primarily U.S. small cap, emerging companies that have improving fundamentals and reasonable valuations.
|Ex-Date||Total Distribution||Income||Short-term Cap Gains||Long-term Cap Gains|
|Dec 13, 1996||$2.031950||—||—||$2.031950|
|Dec 29, 1995||$0.336220||—||—||$0.336220|
|Jul 30, 1993||$0.013330||$0.013330||—||—|
|ANI Pharmaceuticals Inc||1.73%|
|NMI Holdings Inc, Class A||1.61%|
|Willdan Group Inc||1.55%|
|STAAR Surgical Co||1.55%|
|R1 RCM Inc||1.43%|
|BioLife Solutions Inc||1.40%|
|CRA International Inc||1.39%|
|% in Top 10 Holdings||15.04%|
The Fund invests in small-cap, emerging companies that have improving fundamentals (based on growth criteria such as consensus earnings estimates over time and the company's history in meeting earnings targets) and whose stock the portfolio management team believes to be reasonably valued by the market (based on value criteria such as price-to-earnings ratios and free cash flow relative to enterprise value). Cadence defines "emerging companies" as companies it believes have improving fundamentals; are developing new products or technologies, entering new markets or growing market share within existing markets; and whose stock is reasonably valued by the market. Although emerging companies may potentially be found in any market capitalization, Cadence primarily invests in U.S. companies with smaller market capitalizations, in particular those whose market capitalization is within the range of the Russell Microcap® Index and the Russell 2000® Index. The team subjects the most attractively ranked stocks to an analysis of company factors (such as strength of management, competitive industry position and business prospects) and financial statement data to select approximately 75 to 120 stocks to hold in the Fund. The Fund may also invest in real estate investment trusts (REITs).
Cadence Capital Management uses a proprietary quantitative model that seeks to invest in high-quality growth investment strategies across the capitalization spectrum.Learn More
Discover how AMG Funds brings more than 100 products from over 30 independent boutiques together under one flag.Learn More About AMG Funds
You are now leaving the AMG Funds web site: The link you have selected is located on another web site. Please click OK below to leave the AMG Funds site and proceed to the selected site. AMG Funds does not endorse this web site, its sponsor, or any of the policies, activities, products or services offered on the site, or by any advertiser on the site. AMG Funds has no control of the content or data shown on this site, and while AMG Funds has no reason to doubt the reliability of the data shown, its accuracy is not guaranteed. Furthermore, AMG Funds takes no responsibility for the accuracy or factual correctness of any information posted to third party web sites.
Thank you for your interest in AMG Funds.OK